Table 1.
Patient characteristics
| Characteristic | n = 82 |
|---|---|
| Age, year | 64.1 ± 15.6 |
| Dialysis vintage, months | 32.0 ± 28.9 |
| Males | 41 (50%) |
| Diabetes | 18 (22%) |
| Body mass index (kg/m2) | 25.7 ± 5.0 |
| Residual renal function | 23 (28%) |
| Cardiovascular history | 36 (44%) |
| Acute myocardial infarction | 5 (6.1%) |
| Congestive heart failure | 4 (4.9%) |
| Peripheral vascular disease | 17 (20.7%) |
| Cerebral vascular disease | 7 (8.5%) |
| Primary renal disease | |
| Hypertension | 25 (31%) |
| Diabetes | 11 (13%) |
| Glomerulonephritis | 5 (6%) |
| Obstructive uropathy | 14 (17%) |
| ADPKD | 7 (9%) |
| IgA nephropathy | 4 (5%) |
| Alports’ disease | 1 (1%) |
| Other diagnoses | 5 (6%) |
| Unknown | 10 (12%) |
| Cardiovascular medication | |
| Beta-blocker | 48 (59%) |
| CCB | 21 (26%) |
| ACE-I/ ARB | 16 (20%) |
Note: continuous variables are presented as mean ± standard deviation
Abbreviations: ADPKD autosomal dominant polycystic kidney disease, CCB calcium channel blocker; ACE-I angiotensin converting enzyme inhibitor, ARB angiotensin receptor blocker